Real cancer cases up to 3 times higher than reported in India: Report

Real cancer incidence level in India is estimated to be 1.5 to three times higher than reported incidence as 51 per cent patients take more than a week to conclude diagnosis, a report showed

Image: istock
Image: istock
IANS New Delhi
3 min read Last Updated : Oct 11 2022 | 6:28 PM IST

Real cancer incidence level in India is estimated to be 1.5 to three times higher than reported incidence as 51 per cent patients take more than a week to conclude diagnosis while 46 per cent take second opinion due to lack of confidence in initial diagnosis and suggested treatment, a report showed on Tuesday.

The reported cancer incidence in India this year is estimated to be 19 to 20 lakh, whereas real incidence is 1.5 to 3 times higher than the reported cases, according to a study by FICCI and EY titled "Call for Action: Making quality cancer care more accessible and affordable in India".

India is faced with a sizable cancer incidence burden, which continues to grow exponentially.

The 2020 WHO ranking on cancer burden in terms of new yearly cases being reported had ranked India at the third position after China and the US, respectively.

"For cancer prevention, early diagnosis and widespread public awareness will be integral and will serve as a beacon of light to strengthen India's strategy for cancer care and other non-communicable diseases," said Ashok Kakkar, Chair, FICCI Task Force on Cancer Care.

"While some of the most cutting-edge cancer treatment methods and technology are available in our country, we still have a long way to go before we can ensure that cancer patients from every socioeconomic background receive the best possible care," added Kakkar, also Managing Director, Varian Medical Systems International India Pvt Ltd.

Cancer disease burden in India is characterized by poor detection with not more than 29 per cent, 15 per cent and 33 per cent of breast lung and cervical cancers being diagnosed in stages 1 and 2, respectively.

The cancer of the head and neck are found to be progressing at a CAGR of 23 per cent, prostate cancer at 19 per cent, ovarian cancer at 11 per cent and breast cancer at 8 per cent, which is faster than the overall growth rate of incidence.

Six states, which represent 18 per cent of India's population, have 23 per cent share of the country's reported incidence burden and have the highest crude incidence rates.

Kerala, Mizoram, Tamil Nadu, Karnataka, Punjab, and Assam report the highest overall crude incidence rates of cancers which is greater than 130 cases per lakh population, the report mentioned.

Estimates indicate that the total deaths owing to cancer were 8 to 9 lakh in 2020, causing the mortality to incidence ratio for different cancer types in India to be among the poorest compared to global counterparts.

"To address the dual challenge of rising incidence and sub-optimal mortality to incidence ratio, it is imperative to drive mass awareness campaigns, focus on effective prevention and enable improved screening coverage as a primary response,a said Srimayee Chakraborty, Life Sciences Partner, EY India.

--IANS

na/vd

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :cancerIndia

First Published: Oct 11 2022 | 6:28 PM IST

Next Story